<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fasting levels of <z:chebi fb="0" ids="16359">cholic acid</z:chebi> conjugates were determined by radioimmunoassay in the serum of 24 patients with extensively documented <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and in 98 healthy controls without <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> patients studied included <z:hpo ids='HP_0000001'>all</z:hpo> three subtypes, as determined from studies of the plasma disappearance kinetics of sulfobromophthalein and <z:chebi fb="0" ids="31696">indocyanine green</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Although patients with structural <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> severe enough to produce <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> almost invariably have elevated fasting serum levels of <z:chebi fb="0" ids="16359">cholic acid</z:chebi> conjugates, values were <z:mpath ids='MPATH_458'>normal</z:mpath> in each of the <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> patients, including patients with <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> in sulfobromophthalein and <z:chebi fb="0" ids="31696">indocyanine green</z:chebi> transport </plain></SENT>
<SENT sid="3" pm="."><plain>It is concluded that the measurement of fasting serum levels of <z:chebi fb="0" ids="16359">cholic acid</z:chebi> conjugates is a useful adjunct to the diagnosis of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
</text></document>